Aeterna Zentaris
AEZS
#10804
Rank
HK$0.13 B
Marketcap
HK$44.89
Share price
2.14%
Change (1 day)
N/A
Change (1 year)

EPS for Aeterna Zentaris (AEZS)

EPS in 2024 (TTM): -HK$16.03

According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -HK$16.08. In 2022 the company made an earnings per share (EPS) of -HK$36.73 a decrease over its 2021 EPS that were of -HK$14.28.

EPS history for Aeterna Zentaris from 1998 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$16.03
2022-HK$36.73157.14%
2021-HK$14.28-41.48%
2020-HK$24.41-64.46%
2019-HK$68.66-240%
2018HK$49.05-122.32%
2017-HK$219.72-53.53%
2016-HK$472.80-86.71%
2015-HK$3,559-35.21%
2014-HK$5,493-216.67%
2013HK$4,708-123.3%
2012-HK$20,207-40.8%
2011-HK$34,136-6.45%
2010-HK$36,490-27.91%
2009-HK$50,615-61.61%
2008-HK$131,83483.61%
2007-HK$71,803-195.31%
2006HK$75,334178.26%
2005HK$27,073-330%
2004-HK$11,771-80.05%
2003-HK$59,00117.78%
2002-HK$50,095515.93%
2001-HK$8,133-68.6%
2000-HK$25,905119.62%
1999-HK$11,795-3.63%
1998-HK$12,240

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$52.26-425.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$14.93-192.88%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$35.63-321.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.83-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$27.62-271.80%๐Ÿ‡บ๐Ÿ‡ธ USA